Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.17% |
| 2 | Technology | 22.44% |
| 3 | Financials | 11.14% |
| 4 | Consumer Discretionary | 8.06% |
| 5 | Healthcare | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
iShares US Technology ETF
IYW
$25.1B
| $1.15B | 0.07% |
5,773,004
+186,297
| +3% | +$37.3M |
2013 Q2
50 quarters
|
|
252
iShares Core Universal USD Bond ETF
IUSB
$48.9B
| $1.15B | 0.07% |
24,700,344
+1,931,838
| +8% | +$90.3M |
2015 Q1
43 quarters
|
|
253
Southern Company
SO
$105B
| $1.15B | 0.07% |
13,148,239
-812,443
| -6% | -$74.2M |
2013 Q2
50 quarters
|
|
254
iShares Russell Mid-Cap Value ETF
IWS
$15.4B
| $1.14B | 0.07% |
8,071,505
-173,966
| -2% | -$24.3M |
2013 Q2
50 quarters
|
|
255
Rockwell Automation
ROK
$47.3B
| $1.14B | 0.07% |
2,921,840
+276,021
| +10% | +$104M |
2013 Q2
50 quarters
|
|
256
Howmet Aerospace
HWM
$88.1B
| $1.13B | 0.07% |
5,533,106
+39,873
| +0.7% | +$7.94M |
2016 Q4
36 quarters
|
|
257
Republic Services
RSG
$70.9B
| $1.13B | 0.07% |
5,348,501
+1,490,719
| +39% | +$321M |
2013 Q2
50 quarters
|
|
258
TransDigm Group
TDG
$63B
| $1.13B | 0.07% |
852,237
-31,659
| -4% | -$41.5M |
2013 Q2
50 quarters
|
|
259
Cadence Design Systems
CDNS
$88B
| $1.12B | 0.07% |
3,598,438
-710
| -0% | -$232K |
2013 Q2
50 quarters
|
|
260
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $1.12B | 0.07% |
19,747,812
+10,778,683
| +120% | +$606M |
2013 Q2
50 quarters
|
|
261
On Holding
ONON
$11.6B
| $1.12B | 0.07% |
24,119,871
+6,997,455
| +41% | +$302M |
2021 Q3
17 quarters
|
|
262
Otis Worldwide
OTIS
$27.2B
| $1.11B | 0.07% |
12,675,067
-403,770
| -3% | -$36.1M |
2020 Q2
22 quarters
|
|
263
Invesco NASDAQ 100 ETF
QQQM
$106B
| $1.1B | 0.07% |
4,367,200
-453,545
| -9% | -$115M |
2020 Q4
20 quarters
|
|
264
VanEck Gold Miners ETF
GDX
$26.3B
| $1.1B | 0.07% |
12,876,546
+90,514
| +0.7% | +$7.15M |
2013 Q2
50 quarters
|
|
265
Travelers Companies
TRV
$81.2B
| $1.1B | 0.07% |
3,793,750
+85,298
| +2% | +$24M |
2013 Q2
50 quarters
|
|
266
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
| $1.09B | 0.07% |
13,255,860
+1,387,230
| +12% | +$114M |
2013 Q2
50 quarters
|
|
267
iShares China Large-Cap ETF
FXI
$3.89B
| $1.08B | 0.06% |
28,270,283
-2,233,160
| -7% | -$88.6M |
2013 Q2
50 quarters
|
|
268
Morgan Stanley
MS
$284B
| $1.08B | 0.06% |
6,094,734
-55,464
| -0.9% | -$9.25M |
2013 Q2
50 quarters
|
|
269
CBRE Group
CBRE
$38.5B
| $1.08B | 0.06% |
6,691,017
+403,489
| +6% | +$63.4M |
2013 Q2
50 quarters
|
|
270
General Motors
GM
$73.7B
| $1.07B | 0.06% |
13,191,028
+494,404
| +4% | +$34.9M |
2013 Q2
50 quarters
|
|
271
Regeneron Pharmaceuticals
REGN
$81.4B
| $1.07B | 0.06% |
1,389,323
-61,649
| -4% | -$41.9M |
2013 Q2
50 quarters
|
|
272
Vanguard Russell 1000 Growth ETF
VONG
$45.7B
| $1.05B | 0.06% |
8,657,734
-164,298
| -2% | -$20M |
2013 Q2
50 quarters
|
|
273
Cardinal Health
CAH
$58.8B
| $1.05B | 0.06% |
5,122,688
-107,629
| -2% | -$20.3M |
2013 Q2
50 quarters
|
|
274
Idexx Laboratories
IDXX
$44.1B
| $1.05B | 0.06% |
1,553,731
-68,759
| -4% | -$46.8M |
2013 Q2
50 quarters
|
|
275
Janus Henderson AAA CLO ETF
JAAA
$32.1B
| $1.04B | 0.06% |
20,616,010
-1,898,377
| -8% | -$96.1M |
2022 Q1
15 quarters
|
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 428 new, 3,944 increased, 2,959 reduced and 385 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 428 new positions and closed 385 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.